STRATEGIES FOR THE TREATMENT OF TYPE 1 DIABETES AT THE PRE-CONCEPTION STAGE, DURING PREGNANCY AND CHILDBIRTH
Main Article Content
Abstract
The aim of the research – to conduct an analytical review of modern sources of scientific literature covering the treatment of type 1 diabetes at the stage of pregnancy planning, during pregnancy and after childbirth.
Materials and methods. The analysis of 56 domestic and foreign literature sources on this topic was carried out.
Results. Based on the results of the analysis of scientific data, the concept of the treatment of type 1 diabetes before and during pregnancy has been updated.
Conclusion. Type 1 diabetes mellitus is associated with adverse outcomes for fetal matter, but timely pre-conception preparation and therapy during pregnancy can reduce these risks.
Keywords
Article Details
Information about financing and conflict of interests
The authors declare that they have no apparent or potential conflicts of interest related to the publication of this article.
This work is licensed under a Creative Commons Attribution 4.0 License.
How to Cite
References
Cohen AL, Wenger JB, James-Todd T, et al. The association of circulating angiogenic factors and HbA1c with the risk of preeclampsia in women with preexisting diabetes. Hypertens Pregnancy. 2014; 33(1): 81-92. doi: 10.3109/10641955.2013.837175
Wahabi H, Alzeidan R, Bawazeer G, Alansari L, Esmaeil S. Preconception care for diabetic women for improving maternal and fetal outcomes: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2010; 10: 63. doi: 10.1186/1471-2393-10-63
Garg S, Ampudia-Blasco FJ, Pfohl M. Rapid-acting insulin analogues in Basal-bolus regimens in type 1 diabetes mellitus. Endocr Pract. 2010; 16(3): 486-505. doi: 10.4158/EP09294.RA
Ranasinghe PD, Maruthur NM, Nicholson WK, et al. Comparative effectiveness of continuous subcutaneous insulin infusion using insulin analogs and multiple daily injections in pregnant women with diabetes mellitus: a systematic review and meta-analysis. J Womens Health (Larchmt). 2015; 24(3): 237-249. doi: 10.1089/jwh.2014.4939
Tennagels N, Werner U. The metabolic and mitogenic properties of basal insulin analogues. Arch Physiol Biochem. 2013; 119(1): 1-14. doi: 10.3109/13813455.2012.754474
Pollex E, Moretti ME, Koren G, Feig DS. Safety of insulin glargine use in pregnancy: a systematic review and meta-analysis. Ann Pharmacother. 2011; 45: 9-16. doi: 10.1345/aph.1P327
Mathiesen ER, Hod M, Ivanisevic M, Duran Garcia S, Brøndsted L, Jovanovic L, et al. Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes. Diabetes Care. 2012; 35(10): 2012-2017. doi: 10.2337/dc11-2264
Hod M, Mathiesen ER, Jovanovič L, McCance DR, Ivanisevic M, Durán-Garcia S, et al. A randomized trial comparing perinatal outcomes using insulin detemir or neutral protamine Hagedorn in type 1 diabetes. J Matern Fetal Neonatal Med. 2014; 27(1): 7-13. doi: 10.3109/14767058.2013.799650
Valk HW, Visser GH. Insulin during pregnancy, labour and delivery. Best Pract Res Clin Obstet Gynaecol. 2011; 25: 65-76. doi: 10.1016/j.bpobgyn.2010.10.002
James PA, Oparil S, Carter BL, et al. Evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the eighth joint national committee (JNC 8). JAMA. 2014; 311(5): 507-520. doi: 10.1001/jama.2013.284427
Elgina SI, Kondratova LA. Outcomes of pregnancy and childbirth in young people. Mother and Baby in Kuzbass. 2020; 3: 30-34. Russian (Елгина С.И., Кондратова Л.А. Исходы беременности и родов у юных //Мать и Дитя в Кузбассе. 2020. № 3. С. 30-34)
Li DK, Yang C, Andrade S, Tavares V, Ferber JR. Maternal exposure to angiotensin converting enzyme inhibitors in the first trimester and risk of malformations in offspring: a retrospective cohort study. BMJ. 2011; 343: d5931. doi: 10.1136/bmj.d5931
Diav-Citrin O, Shechtman S, Halberstadt Y, et al. Pregnancy outcome after in utero exposure to angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Reprod Toxicol. 2011; 31: 540-545. doi: 10.1016/j.reprotox.2011.02.008
Porta M, Hainer JW, Jansson SO, Malm A, Bilous R, Chaturvedi N, et al. Exposure to candesartan during the first trimester of pregnancy in type 1 diabetes: experience from the placebo-controlled diabetic retinopathy candesartan trials. Diabetologia. 2011; 54: 1298-1303. doi: 10.1007/s00125-010-2040
Yеlgina SI, Ushakova GA. THE Functioning (hormone indexes) of the Newborn girls’ reproductive system in full-term (physiological) and preterm pregnancy. In: Klinicheskie i fundamental'nye aspekty reproduktivnykh problem i zdorov'ya zhenshchiny. Materialy XV mezhdunarodnoy nauchno-prakticheskoy konferentsii. 21-22 aprelya 2011 g. Kemerovo: Meditsina i Prosveshchenie, 2011. Russian (Елгина С.И., Ушакова Г.А. Функциональное состояние репродуктивной системы новорожденных девочек при доношенной и недоношенной беременности. В сб.: Клинические и фундаментальные аспекты репродуктивных проблем и здоровья женщины. Матер. XV междунар. науч.-практ. конф., 21-22 апреля 2011 г. Кемерово: Медицина и Просвещение, 2011)
Yelgina SI, Ushakova GA, Nikulina EN. Reproductive system in full-term and preterm newborn girls. Fundamental and Clinical Medicine. 2016; 1(3): 39-45. Russian (Елгина С.И., Ушакова Г.А., Никулина Е.Н. Оценка репродуктивной системы и состояния овариального резерва у доношенных и недоношенных новорожденных девочек //Фундаментальная и клиническая медицина. 2016. Т. 1, № 3. С. 39-45)
Magee LA, CHIPS Study Group; von Dadelszen P, Singer J, Lee T, Rey E, Ross S et al. Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In pregnancy study (CHIPS) trial. BJOG. 2016; 123(7): 1143-1151. doi: 10.1111/1471-0528.13569
Chung JH, Melsop KA, Gilbert WM, Caughey AB, Walker CK, Main EK. Increasing pre-pregnancy body mass index is predictive of a progressive escalation in adverse pregnancy outcomes. J Matern Fetal Neonatal Med. 2012; 0: 1-23
Johansson K, Cnattingius S, Näslund I, Roos N, Trolle Lagerros Y, Granath F, et al. Outcomes of pregnancy after bariatric surgery. N Engl J Med. 2015; 372(9): 814-824. doi: 10.1056/NEJMoa1405789
Middelbeek RJ, James-Todd T, Cavallerano JD, Schlossman DK, Patti ME, Brown FM. Gastric bypass surgery in severely obese women with type 1 diabetes: anthropometric and cardiometabolic effects at 1 and 5 years postsurgery. Diabetes Care. 2015; 38(7): e104-105. doi: 10.2337/dc15-0396
Duntas LH, Orgiazzi J, Brabant G. The Interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011; 75(1): 1-9. doi: 10.1111/j.1365-2265.2011.04029.x
Catalano PM, Hauguel-De MS. Is it time to revisit the Pedersen hypothesis in the face of the obesity epidemic? Am J Obstet Gynecol. 2011; 204: 479-487. doi: 10.1016/j.ajog.2010.11.039
Elgina SI, Nikulina EN. Predicting a decrease in ovarian reserve in adolescent girls. Mother and Baby in Kuzbass. 2020; 1: 23-31. Russian (Елгина С.И., Никулина Е.Н. Прогнозирование снижения овариального резерва у девушек-подростков //Мать и Дитя в Кузбассе. 2020. № 1. С. 23-31)
Lindsay RS, Nelson SM, Walker JD, et al. Programming of adiposity in offspring of mothers with type 1 diabetes at age 7 years. Diabetes Care. 2010; 33: 1080-1085. doi: 10.2337/dc09-1766
American Diabetes Association Management of diabetes in pregnancy. Sec. 12. In standards of medical care in diabetes 2016. Diabetes Care. 2016; 39(1): S94-S98
Secher AL, Ringholm L, Andersen HU, et al. The effect of real-time continuous glucose monitoring in pregnant women with diabetes. Diabetes Care. 2013; 36(7): 1877-1883. doi: 10.2337/dc12-2360
Law GR, Ellison GT, Secher A, et al. Analysis of continuous glucose monitoring in pregnant women with diabetes: disting temportal patterns of glucose associated with large-for-gestational-age infants. Diabetes Care. 2015; 38: 1319-1324. doi: 10.2337/dc15-0070
Garcia-Patterson A, Gich I, Amini SB, Catalano PM, de Leiva A, Corcoy R. Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia. 2010; 53: 446-451. doi: 10.1007/s00125-009-1633-z
Callesen NF, Ringholm L, Stage E, Damm P, Mathiesen ER. Insulin requirements in type 1 diabetic pregnancy: Do twin pregnant women require twice as much insulin as singleton pregnant women? Diabetes Care. 2012; 35: 1246-1248. doi: 10.2337/dc11-2467
Zisser HC, Biersmith MA, Jovanovic LB, Yogev Y, Hod M, Kovatchev BP. Fetal risk assessment in pregnancies complicated by diabetes mellitus. J Diabetes Sci Technol. 2010; 4: 1368-1373. doi: 10.1177/193229681000400610
Abalos E, Duley L, Steyn DW. Antihypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev. 2014; 6: 2
Huang T, Brown FM, Curran A, James-Todd T. Association of pre-pregnancy BMI and postpartum weight retention with postpartum HbA1c among women with Type 1 diabetes. Diabet Med. 2015; 32(2): 181-188. doi: 10.1111/dme.12617
Magee LA, von Dadelszen P, Rey E, et al. Less-tight versus tight control of hypertension in pregnancy. N Engl J Med. 2015; 372(5): 407-417. doi: 10.1056/NEJMoa1404595
Вeglova AYu, Elgina SI. Diagnostics of PCOS based on clinical and anamnestic factors, laboratory and ultrasound markers using a computer program. Obstetrics and Gynecology. 2020; 2: 133-140. Russian (Беглова А.Ю., Елгина С.И. Диагностика СПКЯ на основе клинико-анамнестических факторов, лабораторных и ультразвуковых маркеров с применением компьютерной программы //Акушерство и гинекология. 2020. № 2. С. 133-140)
Rothberger S, Carr D, Brateng D, Hebert M, Easterling TR. Pharmacodynamics of clonidine therapy in pregnancy: a heterogeneous maternal response impacts fetal growth. Am J Hypertens. 2010; 23: 1234-1240. doi: 10.1038/ajh.2010.159
Firoz T, Magee LA, MacDonell K, Payne BA, Gordon R, Vidler M, et al. Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review. BJOG. 2014; 121(10): 1210-1218. doi: 10.1111/1471-0528.12737
Roseboom TJ, Ravelli AC, van der Post JA, Painter RC. Maternal characteristics largely explain poor pregnancy outcome after hyperemesis gravidarum. Eur J Obstet Gynecol Reprod Biol. 2011; 156: 56-59. doi: 10.1016/j.ejogrb.2011.01.010
Abas MN, Tan PC, Azmi N, Omar SZ. Ondansetron compared with metoclopramide for hyperemesis gravidarum: a randomized controlled trial. Obstet Gynecol. 2014; 123(6): 1272-1279. doi: 10.1097/AOG.0000000000000242
Koren G. Treating morning sickness in the United States changes in prescribing are needed. Am J Obstet Gynecol. 2014; 211(6): 602-606. doi: 10.1016/j.ajog.2014.08.017
Pignone M, Alberts MJ, Colwell JA, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the american diabetes association, a scientific statement of the american heart association, and an expert consensus document of the american college of cardiology foundation. Diabetes Care. 2010; 33: 1395-1402. doi: 10.2337/dc10-0555
Taguchi N, Rubin ET, Hosokawa A, et al. Prenatal exposure to HMG-CoA reductase inhibitors: effects on fetal and neonatal outcomes. Reprod Toxicol. 2008; 26: 175-177. doi: 10.1016/j.reprotox.2008.06.009
Pacheco LD, Saade GR, Hankins G. Acute myocardial infarction during pregnancy. Clin Obstet Gynecol. 2014; 57(4): 835-843. doi: 10.1097/GRF.0000000000000065
De Groot LD, Abalovich M, Alexander EK, Azizi F, Mestman J, Negro R et al. Management of thyroid dysfunction during pregnancy and the postpartum: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97(8): 2543-2565. doi: 10.1210/jc.2011-2803
Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid. 2011; 21(10): 1081-1125. doi: 10.1089/thy.2011.0087
Bahn RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the american thyroid association and american association of clinical endocrinologists. Endocr Pract. 2011; 17: 456-520. doi: 10.4158/EP.17.3.456
Wojcicki JM, Heyman MB. Maternal omega-3 fatty acid supplementation and risk for perinatal maternal depression. J Matern Fetal Neonatal Med. 2011; 24: 680-686. doi: 10.3109/14767058.2010.521873
Persson M, Pasupathy D, Hanson U, Norman M. Birth size distribution in 3,705 infants born to mothers with type 1 diabetes: a population-based study. Diabetes Care. 2011; 34: 1145-1149. doi: 10.2337/dc10-2406
Al-Agha R, Firth RG, Byrne M, Murray S, Daly S, Foley M, et al. Outcome of pregnancy in type 1 diabetes mellitus (T1DMP): results from combined diabetes-obstetrical clinics in Dublin in three university teaching hospitals (1995-2006). Ir J Med Sci. 2012; 181(1): 105-109. doi: 10.1007/s11845-011-0781-6
Aman J, Hansson U, Ostlund I, Wall K, Persson B. Increased fat mass and cardiac septal hypertrophy in newborn infants of mothers with well-controlled diabetes during pregnancy. Neonatology. 2011; 100: 147-154. doi: 10.1159/000323741
Mulder EJ, Koopman CM, Vermunt JK, de Valk HW, Visser GH. Fetal growth trajectories in Type-1 diabetic pregnancy. Ultrasound Obstet Gynecol. 2010; 36: 735-742. doi: 10.1002/uog.7700
Maresh M, Holmes VA, Patterson CP. Diabetes and Pre-eclampsia Intervention Trial Study Goup et al. Glycemic targets in the second and third trimester of pregnancy for women with type 1 diabetes. Diabetes Care. 2015; 38: 34-42. doi: 10.2337/dc14-1755
Clinical recommendations: Gestational diabetes. Russian Association of Endocrinologists, Russian Association of Obstetricians and Gynecologists, 2016. Russian (Гестационный сахарный диабет: Клинические рекомендации. Российская ассоциация эндокринологов, Российская ассоциация акушеров-гинекологов, 2016)
Murphy HR, Steel SA, Roland JM, et al. Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage. Diabet Med. 2011; 28: 1060-1067. doi: 10.1111/j.1464-5491.2011.03333.x
Knip M, Åkerblom HK, Becker D, et al. TRIGR Study Group. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA. 2014; 311(22): 2279-2287. doi: 10.1001/jama.2014.5610
Hawdon JM. Babies born after diabetes in pregnancy: what are the short- and long-term risks and how can we minimise them? Best Pract Res Clin Obstet Gynaecol. 2011; 25: 91-104. doi: 10.1016/j.bpobgyn.2010.10.005
Mahmood I, Jamal M, Khan N. Effect of mother-infant early skin-to-skin contact on breastfeeding status: a randomized controlled trial. J Coll Physicians Surg Pak. 2011; 21: 601-605. doi: 10.2011/JCPSP.601605